Startseite UR
Einträge von Szalontay, Luca auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 7.
Seitz, Stephan, Buchholz, Stefan, Schally, Andrew Victor, Weber, Florian, Klinkhammer-Schalke, Monika, Inwald, Elisabeth C, Perez, Roberto, Rick, Ferenc G, Szalontay, Luca, Hohla, Florian, Segerer, Sabine, Kwok, Chui Wai, Ortmann, Olaf und Engel, Jörg Bernhard 
(2014)
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
BMC Cancer 14 (1).
Volltext nicht vorhanden.
(2014)
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
BMC Cancer 14 (1).
Volltext nicht vorhanden.
Seitz, Stephan, Buchholz, Stefan, Schally, Andrew V. , Jayakumar, Arumugam R., Weber, Florian, Papadia, Andrea , Rick, Ferenc G. , Szalontay, Luca, Treszl, Andrea, Köster, Frank, Ortmann, Olaf und Hohla, Florian
(2013)
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
Anti-Cancer Drugs 24 (2), S. 150-157.
Volltext nicht vorhanden.
, Jayakumar, Arumugam R., Weber, Florian, Papadia, Andrea , Rick, Ferenc G. , Szalontay, Luca, Treszl, Andrea, Köster, Frank, Ortmann, Olaf und Hohla, Florian
(2013)
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
Anti-Cancer Drugs 24 (2), S. 150-157.
Volltext nicht vorhanden.
Rick, Ferenc G. , Buchholz, Stefan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Aigner, Elmar, Perez, Roberto, Seitz, Stephan, Block, Norman L. und Hohla, Florian
(2012)
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Cell Cycle 11 (13), S. 2518-2525.
Volltext nicht vorhanden.
, Buchholz, Stefan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Aigner, Elmar, Perez, Roberto, Seitz, Stephan, Block, Norman L. und Hohla, Florian
(2012)
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Cell Cycle 11 (13), S. 2518-2525.
Volltext nicht vorhanden.
Rick, Ferenc G. , Seitz, Stephan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Buchholz, Stefan, Block, Norman L. und Hohla, Florian
(2012)
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
Cell Cycle 11 (22), S. 4203-4210.
Volltext nicht vorhanden.
, Seitz, Stephan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Buchholz, Stefan, Block, Norman L. und Hohla, Florian
(2012)
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
Cell Cycle 11 (22), S. 4203-4210.
Volltext nicht vorhanden.
Hohla, Florian, Buchholz, Stefan, Schally, Andrew V. , Krishan, Awtar, Rick, Ferenc G. , Szalontay, Luca, Papadia, Andrea , Halmos, Gabor, Koster, Frank, Aigner, Elmar, Datz, Christian und Seitz, Stephan
(2010)
Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.
Cancer Letters 294 (1), S. 35-42.
Volltext nicht vorhanden.
, Krishan, Awtar, Rick, Ferenc G. , Szalontay, Luca, Papadia, Andrea , Halmos, Gabor, Koster, Frank, Aigner, Elmar, Datz, Christian und Seitz, Stephan
(2010)
Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.
Cancer Letters 294 (1), S. 35-42.
Volltext nicht vorhanden.
Hohla, Florian, Buchholz, Stefan, Schally, Andrew V , Seitz, Stefan, Rick, Ferenc G. , Szalontay, Luca, Varga, Jozsef L., Zarandi, Marta, Halmos, Gabor, Vidaurre, Irving, Krishan, Awtar, Kurtoglu, Metin, Chandna, Sudhir , Aigner, Elmar und Datz, Christian
(2009)
GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells.
Cell Cycle 8 (19), S. 3149-3156.
Volltext nicht vorhanden.
, Seitz, Stefan, Rick, Ferenc G. , Szalontay, Luca, Varga, Jozsef L., Zarandi, Marta, Halmos, Gabor, Vidaurre, Irving, Krishan, Awtar, Kurtoglu, Metin, Chandna, Sudhir , Aigner, Elmar und Datz, Christian
(2009)
GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells.
Cell Cycle 8 (19), S. 3149-3156.
Volltext nicht vorhanden.
Seitz, Stephan, Schally, Andrew V. , Treszl, Andrea, Papadia, Andrea , Rick, Ferenc , Szalontay, Luca, Szepeshazi, Karoly, Ortmann, Olaf, Halmos, Gabor, Hohla, Florian und Buchholz, Stefan
(2009)
Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition.
Anti-Cancer Drugs 20 (7), S. 553-558.
Volltext nicht vorhanden.
, Treszl, Andrea, Papadia, Andrea , Rick, Ferenc , Szalontay, Luca, Szepeshazi, Karoly, Ortmann, Olaf, Halmos, Gabor, Hohla, Florian und Buchholz, Stefan
(2009)
Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition.
Anti-Cancer Drugs 20 (7), S. 553-558.
Volltext nicht vorhanden.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707